Enovis Corp

NYSE ENOV

Download Data

Enovis Corp Selling, General, and Administrative Expenses (SG&A) 5 year CAGR for the quarter ending March 31, 2024

Enovis Corp Selling, General, and Administrative Expenses (SG&A) 5 year CAGR is NA for the quarter ending March 31, 2024. Selling, General, and Administrative Expenses (SG&A) consit of the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Enovis Corp Selling, General, and Administrative Expenses (SG&A) for the quarter ending March 31, 2023 was USD 207.16 M, a -43.92% change year over year.
  • Enovis Corp Selling, General, and Administrative Expenses (SG&A) for the quarter ending March 31, 2022 was USD 369.39 M, a 20.82% change year over year.
  • Enovis Corp Selling, General, and Administrative Expenses (SG&A) for the quarter ending March 31, 2021 was USD 305.72 M.
NYSE: ENOV

Enovis Corp

CEO Mr. Mitchell P. Rales
IPO Date May 8, 2008
Location United States
Headquarters 2711 Centerville Road, Wilmington, DE, United States, 19808
Employees 6,550
Sector Industrials
Industry Specialty industrial machinery
Description

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Similar companies

HURC

Hurco Companies Inc

NA

NA

IEX

IDEX Corporation

NA

NA

DCI

Donaldson Company Inc

NA

NA

EPAC

Enerpac Tool Group Corp

NA

NA

KAI

Kadant Inc

NA

NA

GHM

Graham Corporation

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email